Exact Mass: 452.21585519999996
Exact Mass Matches: 452.21585519999996
Found 250 metabolites which its exact mass value is equals to given mass value 452.21585519999996
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3b,12b-Etheno-4H-cyclopenta(1,2)phenanthro(9,10-c)furan-1,3-dione, 10-acetyl-5-(acetyloxy)-3a,5,6,7,7a,9,9a,10,11,12,12a,12c-dodecahydro-7a,9a-dimethyl-
(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride
2'-Methoxykurarinone
(2S)-2-methoxykurarinone is a dimethoxyflavanone that is (2S)-(-)-kurarinone in which the hydroxy group at position 2 is replaced by a methoxy group. Isolated from the roots of Sophora flavescens, it exhibits cytotoxicity against human myeloid leukemia HL-60 cells. It has a role as a metabolite and an antineoplastic agent. It is a dimethoxyflavanone, a dihydroxyflavanone and a member of 4-hydroxyflavanones. It is functionally related to a (2S)-(-)-kurarinone. (2S)-2-methoxykurarinone is a natural product found in Sophora flavescens with data available. A dimethoxyflavanone that is (2S)-(-)-kurarinone in which the hydroxy group at position 2 is replaced by a methoxy group. Isolated from the roots of Sophora flavescens, it exhibits cytotoxicity against human myeloid leukemia HL-60 cells. (2S)-2'-Methoxykurarinone, a compound isolated from the roots of Sophora flavescens, has anti-inflammatory, antipyretic, antidiabetic, and antineoplastic effects. (2S)-2'-Methoxykurarinone (MK) inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. (2S)-2'-Methoxykurarinone (MK) displays cytotoxic activity against human myeloid leukemia HL-60 cells[1][2]. (2S)-2'-Methoxykurarinone, a compound isolated from the roots of Sophora flavescens, has anti-inflammatory, antipyretic, antidiabetic, and antineoplastic effects. (2S)-2'-Methoxykurarinone (MK) inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. (2S)-2'-Methoxykurarinone (MK) displays cytotoxic activity against human myeloid leukemia HL-60 cells[1][2].
28-Deoxonimbolide
28-deoxonimbolide is a limonoid isolated from Azadirachta indica. It has a role as an antineoplastic agent and a plant metabolite. It is an organic heteropentacyclic compound, a cyclic terpene ketone, an enone, a member of furans, a limonoid and a methyl ester. 28-Deoxonimbolide is a natural product found in Azadirachta indica with data available. A limonoid isolated from Azadirachta indica.
(R)-Oct-1-en-3-yl O-??-L-arabinopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
C20H36O11 (452.22575059999997)
lespeflorin G3
A member of the class of pterocarpans that is (6aR,11aR)-pterocarpan substituted by hydroxy groups at positions 3 and 8, methoxy groups at positions 1 and 9 and prenyl groups at positions 2 and 10. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
2-(3,4-dimethoxyphenyl)-6-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one|6-geranyl-5,7-dihydroxy-3,4-dimethoxyflavanone
ochrindole A
C29H28N2O3 (452.20998180000004)
A bisindole alkaloid that is phenol bearing a 3,3-dimethylallyl group at position 4, two methoxy groups at positions 3 and 6, and two indol-3-yl groups at positions 2 and 5. It is a natural product isolated from the sclerotia of Aspergillus orbraceus, with moderate activity against some insects, as well as Gram-positive bacteria.
(2S)-5,7,4-trihydroxy-2-methoxy-8,5-di(3-methyl-2-butenyl)-6-methylflavanone
4-hydroxy-5,7-dimethoxy-6,3-diprenylisoflavanquinone|licoriquinone A
1alpha-(3-furanoyloxy)-9beta-benzoyloxy-dihydro-beta-agarofuran
(3R)-5,8-di-(gamma,gamma-dimethylallyl)-2,5-dihydroxyl-4,7-dimethoxyl-isoflavanone
5,3?-dihydroxy-7,4?-dimethoxy-6,8-dimethylallylflavanone|prenylutiline
1,3,5,7-tetrahydroxy-2-isoprenyl-8-geranylxanthone|cratoxyarborenone A
Ala Cys Phe Ile
Ala Cys Phe Leu
Ala Cys Ile Phe
Ala Cys Leu Phe
Ala Phe Cys Ile
Ala Phe Cys Leu
Ala Phe Ile Cys
Ala Phe Leu Cys
Ala Ile Cys Phe
Ala Ile Phe Cys
Ala Leu Cys Phe
Ala Leu Phe Cys
Cys Ala Phe Ile
Cys Ala Phe Leu
Cys Ala Ile Phe
Cys Ala Leu Phe
Cys Phe Ala Ile
Cys Phe Ala Leu
Cys Phe Ile Ala
Cys Phe Leu Ala
Cys Ile Ala Phe
Cys Ile Phe Ala
Cys Leu Ala Phe
Cys Leu Phe Ala
Phe Ala Cys Ile
Phe Ala Cys Leu
Phe Ala Ile Cys
Phe Ala Leu Cys
Phe Cys Ala Ile
Phe Cys Ala Leu
Phe Cys Ile Ala
Phe Cys Leu Ala
Phe Gly Met Val
Phe Gly Val Met
Phe Ile Ala Cys
Phe Ile Cys Ala
Phe Leu Ala Cys
Phe Leu Cys Ala
Phe Met Gly Val
Phe Met Val Gly
Phe Val Gly Met
Phe Val Met Gly
Gly Phe Met Val
Gly Phe Val Met
Gly Met Phe Val
Gly Met Val Phe
Gly Val Phe Met
Gly Val Met Phe
Ile Ala Cys Phe
Ile Ala Phe Cys
Ile Cys Ala Phe
Ile Cys Phe Ala
Ile Phe Ala Cys
Ile Phe Cys Ala
Leu Ala Cys Phe
Leu Ala Phe Cys
Leu Cys Ala Phe
Leu Cys Phe Ala
Leu Phe Ala Cys
Leu Phe Cys Ala
Met Phe Gly Val
Met Phe Val Gly
Met Gly Phe Val
Met Gly Val Phe
Met Val Phe Gly
Met Val Gly Phe
2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-7-hydroxy- glucuronide
C22H32N2O8 (452.21585519999996)
Val Phe Gly Met
Val Phe Met Gly
Val Gly Phe Met
Val Gly Met Phe
Val Met Phe Gly
Val Met Gly Phe
2-CYCLOHEXYLETHYL-BETA-D-MALTOSIDE
C20H36O11 (452.22575059999997)
2-[4-[2-[4-[2-(2-methylprop-2-enoyloxy)ethoxy]phenyl]propan-2-yl]phenoxy]ethyl 2-methylprop-2-enoate
N-DANSYL-L-THREONINE CYCLOHEXYLAMMONIUM
C22H34N3O5S+ (452.2219054000001)
Dexamethasone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
3-(8-((Dimethylamino)methyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
1-Benzyl-2,3-dimethylguanidinium sulphate (2:1)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
phosphono [(2E,7S,10E)-3,7,11,15-tetramethylhexadeca-2,10,14-trienyl] hydrogen phosphate
C20H38O7P2 (452.20926579999997)
Bethanidine Sulfate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
bis{N-[(benzylamino)(methylamino)methylidene]methanaminium} sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
Arisugacin C
An organic heterotetracyclic compound that is 4,4,6a,12b-tetramethyl-1,4a,5,6,6a,12,12a,12b-octahydro-2H,11H-benzo[f]pyrano[4,3-b]chromene-3,11(4H)-dione substituted at position 4a by a hydroxy and and at position 9 by 4-methoxyphenyl group (the 4aS,6aR,12aR,12bR stereoisomer). Isolated from the culture broth of Penicillium, it acts as a selective inhibitor of acetylcholinesterase.
[2-Methoxy-5-[[4-(4-methylphenyl)-1-phthalazinyl]amino]phenyl]-(1-piperidinyl)methanone
15,16-epoxy-8alpha-(benzoyloxy)methyl-2R-hydroxycleroda-3,13(16),14-trien-18-oic acid, (rel)-
A natural product found in Dodonaea polyandra.
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(2-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
C29H28N2O3 (452.20998180000004)
(1R)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoate
C23H34NO6S- (452.2106724000001)
[4-[Hydroxy(diphenyl)methyl]-1-triazolyl]-[4-(phenylmethyl)-1-piperidinyl]methanone
20-oxoleukotriene E4(1-)
C23H34NO6S (452.2106724000001)
A leukotriene anion that is the conjugate base of leukotriene E4 obtained by deprotonation of the two carboxy groups and protonation of the cysteinyl alpha-amino group; major species at pH 7.3.
(-)-(S)-B-973B
(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1]. (-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].
KT172
KT172 is a DAGLβ inhibitor with an IC50 value of 11 nM. KT172 can be used for the research of metabolic and inflammatory[1].
7-hydroxy-2-(2-hydroxy-4-methoxyphenyl)-5-methoxy-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
(2s)-5,7-dihydroxy-2-[4-hydroxy-2-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-6-methyl-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-(oct-1-en-3-yloxy)-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
C20H36O11 (452.22575059999997)
(2s)-5-hydroxy-2-(2-hydroxy-4-methoxyphenyl)-7-methoxy-6-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
(2r)-7-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-5,10-dihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
13-[(benzoyloxy)methyl]-1-hydroxy-8-isopropyl-2-methyl-15-oxatetracyclo[10.2.1.0²,¹⁰.0⁵,⁹]pentadeca-8,13-diene-5-carboxylic acid
(2s)-9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7,10-trihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
2'-methoxykurarinone
{"Ingredient_id": "HBIN005915","Ingredient_name": "2'-methoxykurarinone","Alias": "NA","Ingredient_formula": "C27H32O6","Ingredient_Smile": "CC(=CCC(CC1=C2C(=C(C=C1O)OC)C(=O)CC(O2)C3=C(C=C(C=C3)O)OC)C(=C)C)C","Ingredient_weight": "452.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16513","TCMID_id": "13978","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "133561937","DrugBank_id": "NA"}
(1r,10r)-3,14-dimethoxy-4,15-bis(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11,13,15-hexaene-5,13-diol
3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-8,8-dimethyl-5-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)bicyclo[3.3.2]decane-2,4,9-trione
(12s,13s)-15-[5-(3-chloro-1h-pyrrol-2-yl)-3-methoxyfuran-2-yl]-13-isopropyl-2-azatricyclo[10.2.1.1³,¹⁴]hexadeca-1(15),2,14(16)-triene
C27H33ClN2O2 (452.22304280000003)
4a,6-dihydroxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,5h,6h,6ah,7h,11ah-phenanthro[3,2-b]furan-5-yl benzoate
(2r,3s,4s,5s,6s)-2-[(3r)-oct-1-en-3-yloxy]-6-({[(2r,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
C20H36O11 (452.22575059999997)
(4ar,5r,6r,6as,7r,11as,11br)-4a,6-dihydroxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,5h,6h,6ah,7h,11ah-phenanthro[3,2-b]furan-5-yl benzoate
(1r,5s,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-1-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)bicyclo[3.3.2]dec-3-ene-2,10-dione
methyl 2-[(1r,2s,4r,6r,9r,10s,11r,15s,18r)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
5-hydroxy-4,5,7a,7b-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethenyl]-hexahydronaphtho[1,2-b]oxiren-7-yl benzoate
(2s,3s)-3-{[(3s)-3-amino-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene]amino}-6-[2-hydroxy-5-(hydroxymethyl)-4-iminopyrimidin-1-yl]-3,6-dihydro-2h-pyran-2-carboxylic acid
6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7,10-trihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
9-(3,7-dimethylocta-2,6-dien-1-yl)-5,7,10-trihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
4-(3,4-dihydroxybenzoyl)-2-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(3-methylbut-2-en-1-yl)cyclopent-4-ene-1,3-dione
methyl 2-[(1r,2s,4s,6r,9r,10s,11r,15r,18s)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
(2r,5s,10r,12r)-13-[(benzoyloxy)methyl]-1-hydroxy-8-isopropyl-2-methyl-15-oxatetracyclo[10.2.1.0²,¹⁰.0⁵,⁹]pentadeca-8,13-diene-5-carboxylic acid
(2s)-6-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
methyl 2-[(1r,2s,4r,9r,10s,11r,15r,18s)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
(2e)-1-{2,4-dihydroxy-6-methoxy-3-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]phenyl}-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one
(2s,3s,5s)-2-(oct-1-en-3-yloxy)-6-({[(2s,3s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
C20H36O11 (452.22575059999997)
methyl 2-[(1r,2s,4r,6r,9r,10s,11r,18r)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
(2s)-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-6,8-bis(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-(3,4-dimethoxyphenyl)-6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
5-[(3r)-5,7-dimethoxy-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-3-yl]-2-hydroxy-3-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione
(1s,3s,4r,4as,8s,8ar)-3-hydroxy-3,4,8,8a-tetramethyl-7-oxo-4-[(1e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-hexahydronaphthalen-1-yl benzoate
3-hydroxy-3,4,8,8a-tetramethyl-7-oxo-4-[2-(5-oxo-2h-furan-3-yl)ethenyl]-hexahydronaphthalen-1-yl benzoate
7a-hydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-6,7,10,11,11b,12-hexahydro-2,5-dioxatetraphene-1,9-dione
9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7,10-trihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
(12r,13r)-15-[5-(3-chloro-1h-pyrrol-2-yl)-3-methoxyfuran-2-yl]-13-isopropyl-2-azatricyclo[10.2.1.1³,¹⁴]hexadeca-1(15),2,14(16)-triene
C27H33ClN2O2 (452.22304280000003)
(1s,2s,11r,19s)-6,11,14,19-tetramethyl-4-(3-methylbut-2-en-1-yl)-10,12,20-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-3(8),4,6,13(21),14,16-hexaene-5,7,15-triol
(2e)-1-{2,4-dihydroxy-6-methoxy-3-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]phenyl}-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one
methyl 2-[(1r,2r)-2-[(1r,8ar)-1-(furan-3-yl)-8a-methyl-5-methylidene-3-oxo-1,6,7,8-tetrahydroisochromen-6-yl]-2,6,6-trimethyl-5-oxocyclohex-3-en-1-yl]acetate
7-[(3,7-dimethylocta-2,6-dien-1-yl)oxy]-5,10-dihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
7-hydroxy-2-(4-hydroxy-2-methoxyphenyl)-5-methoxy-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
(1r,5r,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-1-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)bicyclo[3.3.2]dec-3-ene-2,10-dione
3-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-1-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)bicyclo[3.3.2]dec-3-ene-2,10-dione
(2s)-7-hydroxy-2-(2-hydroxy-4-methoxyphenyl)-5-methoxy-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
1-{2,4-dihydroxy-6-methoxy-3-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]phenyl}-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one
(3r)-3-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-5,7-dimethoxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2r)-7-hydroxy-2-(4-hydroxy-2-methoxyphenyl)-5-methoxy-8-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
7-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-5,10-dihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
(2r)-6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7,10-trihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7,10-trihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
(13s)-15-[(2z)-5-[(2z)-3-chloropyrrol-2-ylidene]-3-methoxyfuran-2-ylidene]-13-isopropyl-2-azatricyclo[10.2.1.1³,¹⁴]hexadeca-1(14),3(16)-diene
C27H33ClN2O2 (452.22304280000003)
6-(4,8-dimethylnona-3,7-dien-1-yl)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(2r,3r,4s,5s,6r)-2-[(3r)-oct-1-en-3-yloxy]-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
C20H36O11 (452.22575059999997)
(2s)-2-{2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-hydroxy-4-methoxyphenyl}-5-hydroxy-7-methoxy-2,3-dihydro-1-benzopyran-4-one
methyl 2-[6-(furan-2-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
(2s)-2-(3,4-dimethoxyphenyl)-6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(4ar,5r,6r,6as,7r,11ar,11br)-4a,6-dihydroxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,5h,6h,6ah,7h,11ah-phenanthro[3,2-b]furan-5-yl benzoate
(1r,2s,3r,4r,4as,8ar)-2,3-dihydroxy-3,4,8,8a-tetramethyl-4-[(1e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl benzoate
(1ar,3ar,4r,5s,7s,7as,7bs)-5-hydroxy-4,5,7a,7b-tetramethyl-4-[(1e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-hexahydronaphtho[1,2-b]oxiren-7-yl benzoate
methyl 2-[(1r,2s,4s,6r,9r,10s,11r,15r,18r)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
(2s)-7-hydroxy-2-(2-hydroxy-4-methoxyphenyl)-5-methoxy-8-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
methyl 2-[6-(furan-3-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
2-[2-(3,7-dimethylocta-2,6-dien-1-yl)-3-hydroxy-4-methoxyphenyl]-5-hydroxy-7-methoxy-2,3-dihydro-1-benzopyran-4-one
methyl 2-[(1r,2s,4r,6r,9r,10s,11r,15r,18s)-6-(furan-2-yl)-7,9,11,15-tetramethyl-12-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,13-dien-10-yl]acetate
2,5-bis(1h-indol-3-yl)-3,6-dimethoxy-4-(3-methylbut-2-en-1-yl)phenol
C29H28N2O3 (452.20998180000004)